Fifth Third Bancorp
APLS

Fifth Third Bancorp’s Apellis Pharmaceuticals APLS Stock Holding History

Fifth Third Bancorp’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,102
Closed -$889K – 4346
2026
Q1 		$889K Buy
+22,102
New +$476K ﹤0.01% 1713

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fifth Third Bancorp's APLS Position: Q2 2026 in Review

Fifth Third Bancorp sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 22,102 shares — an estimated $889K sold.

Fifth Third Bancorp first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $889K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Fifth Third Bancorp reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Fifth Third Bancorp sold 22,102 Apellis Pharmaceuticals shares in Q2 2026, an estimated $889K.
  • Fifth Third Bancorp first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Fifth Third Bancorp's Apellis Pharmaceuticals position peaked at $889K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.